scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Yoland Smith | |
Rosa M Villalba | |||
P2860 | cites work | The familial Parkinsonism gene LRRK2 regulates neurite process morphology | Q24317613 |
Morphological changes in dendritic spines associated with long-term synaptic plasticity | Q29614372 | ||
The functional anatomy of basal ganglia disorders | Q29617461 | ||
Primate models of movement disorders of basal ganglia origin | Q29618489 | ||
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons | Q29619181 | ||
Evidence of a breakdown of corticostriatal connections in Parkinson's disease. | Q33214147 | ||
The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones | Q33256442 | ||
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure. | Q33319566 | ||
Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis | Q33595218 | ||
A neurocomputational method for fully automated 3D dendritic spine detection and segmentation of medium-sized spiny neurons | Q33729745 | ||
Dendritic spine formation and pruning: common cellular mechanisms? | Q33826755 | ||
Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens | Q33904968 | ||
Lrrk2 localization in the primate basal ganglia and thalamus: a light and electron microscopic analysis in monkeys | Q34005501 | ||
Pathophysiology of the basal ganglia in Parkinson's disease. | Q34070859 | ||
Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss | Q34116613 | ||
Ca(2+) signaling in dendritic spines | Q34278072 | ||
Genesis of dendritic spines: insights from ultrastructural and imaging studies | Q34288088 | ||
The thalamostriatal system: a highly specific network of the basal ganglia circuitry | Q34550491 | ||
Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 | ||
Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements | Q35932567 | ||
Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease | Q35991189 | ||
Calcium regulation of actin dynamics in dendritic spines. | Q36093658 | ||
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. | Q36145938 | ||
Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons | Q36169973 | ||
Perforated postsynaptic densities: probable intermediates in synapse turnover | Q36312956 | ||
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism | Q36763909 | ||
Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. | Q36946633 | ||
Balancing structure and function at hippocampal dendritic spines | Q37088448 | ||
Dendritic spine plasticity--current understanding from in vivo studies. | Q37114209 | ||
The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states | Q37130756 | ||
Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys | Q37186952 | ||
Altered dendritic spine plasticity in cocaine-withdrawn rats | Q37233538 | ||
Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains | Q37264478 | ||
Quantal analysis and synaptic anatomy — integrating two views of hippocampal plasticity | Q40486104 | ||
Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function | Q40766021 | ||
MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. | Q40817289 | ||
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus | Q41241320 | ||
Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. | Q42468515 | ||
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. | Q42493069 | ||
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | Q44102387 | ||
Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism | Q46670738 | ||
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey | Q48117953 | ||
Calbindin D-28k as a marker for the associative cortical territory of the striatum in macaque | Q48191029 | ||
Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. | Q48454428 | ||
Sesquicentenary of the birthday of Santiago Ramón y Cajal, the father of modern neuroscience | Q48508765 | ||
A Golgi study of rat neostriatal neurons: Light microscopic analysis | Q48932428 | ||
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease | Q49069694 | ||
The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. | Q51120870 | ||
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders? | Q58064430 | ||
Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age | Q69262673 | ||
Calcium in the spine apparatus of dendritic spines in the dentate molecular layer | Q72697493 | ||
GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation | Q73491179 | ||
Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway | Q74240596 | ||
Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disorders | Q82029272 | ||
P921 | main subject | Parkinson's disease | Q11085 |
striatum | Q1319792 | ||
P304 | page(s) | 133 | |
P577 | publication date | 2010-12-10 | |
P1433 | published in | Frontiers in Neuroanatomy | Q1893158 |
P1476 | title | Striatal spine plasticity in Parkinson's disease | |
P478 | volume | 4 |
Q46449896 | -NMDA R/+VDR pharmacological phenotype as a novel therapeutic target in relieving motor-cognitive impairments in Parkinsonism |
Q27330366 | Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function |
Q41050952 | Basal Ganglia Circuits: What's Now and Next? |
Q28271277 | Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects |
Q35799129 | Cortical Composition Hierarchy Driven by Spine Proportion Economical Maximization or Wire Volume Minimization |
Q36775249 | Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality? |
Q28591970 | Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice |
Q37185190 | Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? |
Q36256517 | Dopamine D1 Receptor-Mediated Transmission Maintains Information Flow Through the Cortico-Striato-Entopeduncular Direct Pathway to Release Movements |
Q38722989 | Dysregulation of striatal projection neurons in Parkinson's disease |
Q34200166 | Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat |
Q37213655 | Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease. |
Q47786283 | Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons. |
Q38766091 | Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity? |
Q48377970 | Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease |
Q26781619 | Morphological changes of glutamatergic synapses in animal models of Parkinson's disease |
Q35176103 | Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease |
Q30389213 | On the Complexity of Brain Disorders: A Symptom-Based Approach |
Q49825935 | Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP+ Toxicity In Vivo |
Q36379339 | Recent advances in applying mass spectrometry and systems biology to determine brain dynamics. |
Q28648007 | Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia |
Q31105385 | Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression |
Q91750012 | Structural plasticity of GABAergic and glutamatergic networks in the motor thalamus of parkinsonian monkeys |
Q26864858 | The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond |
Q38922002 | The cellular basis of dendrite pathology in neurodegenerative diseases |
Q35146020 | The corticostriatal and corticosubthalamic pathways: two entries, one target. So what? |
Q36951038 | The role of exercise in facilitating basal ganglia function in Parkinson's disease |
Q26996624 | The thalamostriatal system in normal and diseased states |
Q34390400 | Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease |
Q42505593 | Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. |
Q90671795 | What and How Can Physical Activity Prevention Function on Parkinson's Disease? |
Search more.